SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma Advanced Research Company informs about outcome of board meeting

04 Nov 2015 Evaluate

Sun Pharma Advanced Research Company has informed that the Board of Directors of the Company at its meeting held on November 04, 2015, approved the re-appointment of Sudhir Valia as the Director & CFO of the Company, who retires as a CFO on December 31, 2015, for an additional period of two years from January 01, 2016 to December 01, 2018, subject to necessary approvals as may be required.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

217.65 -0.55 (-0.25%)
06-Aug-2026 14:53 View Price Chart
Peers
Company Name CMP
Indegene 558.00
Syngene Internatl. 400.45
CMS Info Systems 276.90
JITF Infralogistics 341.60
Sagility 43.67
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: